AXONE PHARMA: what changed
What changed
AXONE PHARMA
NACE 46.180, Agents specialised in the wholesale of other particular products
filed annual accounts (NBB)
Net result for the year
€1.6m
2024 · €695,941+€915,332
Equity
€8.1m
2024 · €6.5m+€1.6m
Cash
€2.7m
2024 · €1.2m+€1.6m
Balance sheet total
€16.2m
2024 · €9.2m+€7.0m
Largest movements
Assets
- Stocks and contracts +€5.3m
up €5.3m (+121%), from €4.4m to €9.7m
- Cash +€1.6m
up €1.6m (+132%), from €1.2m to €2.7m
mainly Trade debts (+€2.7m) and Other debts (+€2.3m)
Equity and liabilities
- Trade debts +€2.7m
up €2.7m (+138%), from €2.0m to €4.7m
- Other debts +€2.3m
new in 2025: €2.3m
- Profit (loss) carried forward +€1.6m
up €1.6m (+74.3%), from €2.2m to €3.8m
- Accrued charges and deferred income +€254,813
up €254,813 (+89.3%), from €285,411 to €540,224
Income statement
- Turnover +€12.5m
up €12.5m (+86.2%), from €14.5m to €27.1m
- Goods and materials +€9.8m
up €9.8m (+128%), from €7.7m to €17.4m
of which Purchases: +€14.8m
- Services and other goods +€1.1m
up €1.1m (+29.6%), from €3.7m to €4.8m
- Taxes +€300,089
up €300,089 (+98.2%), from €305,677 to €605,765
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Result 2024
€695,941
Turnover
+€12.5m
Other operating income
+€7,760
Goods and materials
-€9.8m
Services and other goods
-€1.1m
Staff costs
-€187,276
Depreciation
-€26,805
Write-downs
-€93,389
Provisions
-€34,761
Other operating charges
-€18,950
Other operating items
+€4,691
Financial income
-€47,960
Financial charges
-€44,021
Taxes
-€300,089
Result 2025
€1.6m
raises the resultlowers the resultnot broken down further in the accounts
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
From operations
+€1.7m
Investment
-€140,285
Financing
€0
Cash 2024
€1.2m
From operations (derived)
+€1.7m
Net result for the year
+€1.6m
Depreciation
+€138,440
Stocks and contracts
-€5.3m
Receivables within one year
-€148,812
Deferred charges and accrued income
+€4,983
Provisions
+€34,761
Trade debts
+€2.7m
Tax, wage and social debts
+€71,475
Advances received
+€14,778
Other debts
+€2.3m
Accrued charges and deferred income
+€254,813
Investment (derived)
-€140,285
Investment in fixed assets (net)
-€140,285
Cash 2025
€2.7m
brings cash intakes cash out
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €9,200,854 | €16,230,903 | +€7.0m | +76.4% |
| Fixed assets | 21/28 | €460,604 | €462,450 | +€1,846 | +0.4% |
| Intangible fixed assets | 21 | €317,853 | €304,958 | -€12,895 | -4.1% |
| Tangible fixed assets | 22/27 | €120,978 | €157,121 | +€36,143 | +29.9% |
| Plant, machinery and equipment | 23 | €53,628 | €52,568 | -€1,060 | -2.0% |
| Furniture and vehicles | 24 | €38,382 | €43,450 | +€5,068 | +13.2% |
| Other tangible fixed assets | 26 | €28,967 | €61,103 | +€32,136 | +111% |
| Financial fixed assets | 28 | €21,773 | €371 | -€21,402 | -98.3% |
| Other financial fixed assets | 284/8 | €21,773 | €371 | -€21,402 | -98.3% |
| Amounts receivable and cash guarantees | 285/8 | €21,773 | €371 | -€21,402 | -98.3% |
| Current assets | 29/58 | €8,740,250 | €15,768,453 | +€7.0m | +80.4% |
| Stocks and contracts in progress | 3 | €4,394,132 | €9,716,188 | +€5.3m | +121% |
| Stocks | 30/36 | €4,394,132 | €9,716,188 | +€5.3m | +121% |
| Goods purchased for resale | 34 | €4,213,875 | €9,682,691 | +€5.5m | +130% |
| Advance payments | 36 | €180,257 | €33,497 | -€146,759 | -81.4% |
| Amounts receivable within one year | 40/41 | €3,099,735 | €3,248,547 | +€148,812 | +4.8% |
| Trade receivables | 40 | €1,793,760 | €3,104,071 | +€1.3m | +73.0% |
| Other amounts receivable | 41 | €1,305,975 | €144,476 | -€1.2m | -88.9% |
| Cash at bank and in hand | 54/58 | €1,187,391 | €2,749,708 | +€1.6m | +132% |
| Deferred charges and accrued income | 490/1 | €58,993 | €54,010 | -€4,983 | -8.4% |
| Total equity and liabilities | 10/49 | €9,200,854 | €16,230,903 | +€7.0m | +76.4% |
| Equity | 10/15 | €6,466,511 | €8,077,783 | +€1.6m | +24.9% |
| Contributions | 10/11 | €300,000 | €300,000 | = | 0.0% |
| Capital | 10 | €300,000 | €300,000 | = | 0.0% |
| Issued capital | 100 | €300,000 | €300,000 | = | 0.0% |
| Reserves | 13 | €3,997,133 | €3,997,133 | = | 0.0% |
| Non-distributable reserves | 130/1 | €30,000 | €30,000 | = | 0.0% |
| Legal reserve | 130 | €30,000 | €30,000 | = | 0.0% |
| Tax-exempt reserves | 132 | €2,121,760 | €41,210 | -€2.1m | -98.1% |
| Distributable reserves | 133 | €1,845,373 | €3,925,923 | +€2.1m | +113% |
| Profit (loss) carried forward | 14 | €2,169,378 | €3,780,650 | +€1.6m | +74.3% |
| Provisions and deferred taxes | 16 | - | €34,761 | +€34,761 | |
| Provisions for liabilities and charges | 160/5 | - | €34,761 | +€34,761 | |
| Other liabilities and charges | 164/5 | - | €34,761 | +€34,761 | |
| Deferred taxes | 168 | - | €0 | = | |
| Amounts payable | 17/49 | €2,734,343 | €8,118,359 | +€5.4m | +197% |
| Amounts payable within one year | 42/48 | €2,448,933 | €7,578,135 | +€5.1m | +209% |
| Trade debts | 44 | €1,987,733 | €4,728,666 | +€2.7m | +138% |
| Suppliers | 440/4 | €1,987,733 | €4,728,666 | +€2.7m | +138% |
| Advances received on contracts in progress | 46 | - | €14,778 | +€14,778 | |
| Taxes, remuneration and social security | 45 | €461,200 | €532,674 | +€71,475 | +15.5% |
| Taxes | 450/3 | €28,521 | €0 | -€28,521 | -100% |
| Remuneration and social security | 454/9 | €432,678 | €532,674 | +€99,996 | +23.1% |
| Other amounts payable | 47/48 | - | €2,302,017 | +€2.3m | |
| Accrued charges and deferred income | 492/3 | €285,411 | €540,224 | +€254,813 | +89.3% |
| Operating income | 70/76A | €14,551,480 | €27,093,832 | +€12.5m | +86.2% |
| Turnover | 70 | €14,546,329 | €27,080,922 | +€12.5m | +86.2% |
| Other operating income | 74 | €5,150 | €12,910 | +€7,760 | +151% |
| Operating charges | 60/66A | €13,612,880 | €24,847,831 | +€11.2m | +82.5% |
| Goods for resale, raw materials and consumables | 60 | €7,663,390 | €17,449,151 | +€9.8m | +128% |
| Purchases | 600/8 | €8,177,626 | €22,997,738 | +€14.8m | +181% |
| Change in stocks: decrease (increase) | 609 | -€514,236 | -€5,548,587 | -€5.0m | -979% |
| Services and other goods | 61 | €3,688,684 | €4,781,385 | +€1.1m | +29.6% |
| Remuneration, social security and pensions | 62 | €2,168,051 | €2,355,326 | +€187,276 | +8.6% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €111,634 | €138,440 | +€26,805 | +24.0% |
| Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) | 631/4 | -€76,454 | €16,934 | +€93,389 | |
| Provisions for liabilities and charges: additions (uses and reversals) | 635/8 | €0 | €34,761 | +€34,761 | |
| Other operating charges | 640/8 | €52,775 | €71,725 | +€18,950 | +35.9% |
| Non-recurring operating charges | 66A | €4,800 | €109 | -€4,691 | -97.7% |
| Operating profit (loss) | 9901 | €938,600 | €2,246,002 | +€1.3m | +139% |
| Financial income | 75/76B | €67,168 | €19,208 | -€47,960 | -71.4% |
| Recurring financial income | 75 | €67,168 | €19,208 | -€47,960 | -71.4% |
| Income from current assets | 751 | €44,444 | €1,862 | -€42,583 | -95.8% |
| Other financial income | 752/9 | €22,724 | €17,346 | -€5,378 | -23.7% |
| Financial charges | 65/66B | €4,151 | €48,172 | +€44,021 | +1,060% |
| Recurring financial charges | 65 | €4,151 | €48,172 | +€44,021 | +1,060% |
| Debt charges | 650 | €954 | €43,683 | +€42,728 | +4,477% |
| Other financial charges | 652/9 | €3,197 | €4,490 | +€1,293 | +40.4% |
| Profit (loss) for the period before taxes | 9903 | €1,001,617 | €2,217,038 | +€1.2m | +121% |
| Income taxes | 67/77 | €305,677 | €605,765 | +€300,089 | +98.2% |
| Taxes | 670/3 | €305,677 | €605,765 | +€300,089 | +98.2% |
| Profit (loss) for the period | 9904 | €695,941 | €1,611,272 | +€915,332 | +132% |
| Transfer from tax-exempt reserves | 789 | €315,750 | €2,080,550 | +€1.8m | +559% |
| Profit (loss) for the period to be appropriated | 9905 | €1,011,691 | €3,691,822 | +€2.7m | +265% |
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Compare this company with its sector.Sector benchmark
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 8 November 2026 via checked.be.